The occurrence of malignant tumors must be decreased or postponed by using synthetic, chemical or biological agents in chronic administration. The potential importance of this method has been shown in studies of breast, prostate and colon cancer. In the last 10 years , new chemical preventive agents have been produced and now include a detailed mechanical pre-clinical evaluation of agents before clinical trials are carried out and a emphasis on evaluating biomarkers of action, which are predictor us for early efficacy. Gastric Cancer Journal, Cancer Research Medical Journal, Breast Cancer Advances, European Cancer Journal provides information on the development of gastrointestinal cancer.
Research Article: Journal of Molecular Cancer
Research Article: Journal of Molecular Cancer
Research Article: Journal of Molecular Cancer
Research Article: Journal of Molecular Cancer
Market Analysis: Journal of Molecular Cancer
Market Analysis: Journal of Molecular Cancer
Research Article: Journal of Molecular Cancer
Research Article: Journal of Molecular Cancer
Research Article: Journal of Molecular Cancer
Research Article: Journal of Molecular Cancer
Posters & Accepted Abstracts: Journal of Molecular Cancer
Posters & Accepted Abstracts: Journal of Molecular Cancer
Posters & Accepted Abstracts: Journal of Molecular Cancer
Posters & Accepted Abstracts: Journal of Molecular Cancer
Posters & Accepted Abstracts: Journal of Molecular Cancer
Posters & Accepted Abstracts: Journal of Molecular Cancer
ScientificTracks Abstracts: Journal of Molecular Cancer
ScientificTracks Abstracts: Journal of Molecular Cancer
Keynote: Journal of Molecular Cancer
Keynote: Journal of Molecular Cancer